Whereas our results do not indicate any negative impact of PTPN2 inhibition on myogenesis, we cannot exclude the contribution of PTPN2 in K884 treatment and the impact of inhibiting both phosphatases will need to be investigated in the context of developing PTPN1/2 inhibitors for therapeutic application in DMD. Here, PTPN1 is linked to Duchenne muscular dystrophy.